Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3183539/0/en/GenVivo-to-Present-Phase-1-Trial-Results-for-GEN2-A-Personalizing-Systemic-Cancer-Immunotherapy-at-the-2025-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148400/0/en/GenVivo-Strengthens-Oncology-Leadership-with-Appointment-of-Noriyuki-Kasahara-M-D-Ph-D-as-Chief-Scientific-Officer.html

21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085602/0/en/GenVivo-Highlights-Non-Integrating-Retroviral-Vector-Technology-with-Persistent-Payload-Expression-at-the-2025-Retroviruses-Meeting.html

13 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/13/3079932/0/en/GenVivo-Highlights-GEN2-Phase-1-Data-and-GEN-1013-Preclinical-Data-at-the-2025-American-Society-of-Gene-Cell-Therapy-ASGCT-Annual-Meeting.html

26 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/26/3068699/0/en/GenVivo-Highlights-GEN-1013-A-Novel-Delivery-of-an-IL-12-Immunotherapy-at-the-2025-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

08 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/08/2977483/0/en/GenVivo-to-Present-Phase-1-Trial-Results-for-GEN2-A-Personalizing-Gene-Vector-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
ABOUT THIS PAGE